Medtronic Moves Closer To Closed-Loop Diabetes Care With Paradigm
This article was originally published in The Gray Sheet
Executive Summary
Earlier-than-anticipated approval of its Paradigm real-time insulin pump and continuous glucose monitoring system again puts Medtronic one step ahead of the competition in moving toward "closed-loop" diabetes management, the company suggests